Overview

  • Product nameAnti-RNF41 antibody
    See all RNF41 primary antibodies
  • Description
    Rabbit polyclonal to RNF41
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Rabbit, Horse, Guinea pig, Cow, Dog, Pig, Chimpanzee, Rhesus monkey, Gorilla, Orangutan, Platypus (Ornithorhynchus anatinus)
  • Immunogen

    Synthetic peptide corresponding to a region within C terminal residues 275 - 317 of Human RNF41 (NP_005776.1). Note: the amino acid sequence is considered to be commercially sensitive.

  • Positive control
    • Prostate adenocarcinoma or metastatic lymph node.

Properties

Applications

Our Abpromise guarantee covers the use of ab84409 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P
  • Application notesIHC-P: 1/100 - 1/500. Antigen retrieval with citrate buffer will enhance staining.
    Note: expected to work on frozen sections.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionActs as E3 ubiquitin-protein ligase and regulates the degradation of target proteins. Polyubiquitinates MYD88 and Negatively regulates MYD88-dependent production of proinflammatory cytokines but can promote TRIF-dependent production of type I interferon. Promotes also activation of TBK1 and IRF3. Involved in the ubiquitination of erythropoietin (EPO) and interleukin-3 (IL-3) receptors. Thus, through maintaining basal levels of cytokine receptors, RNF41 is involved in the control of hematopoietic progenitor cell differentiation into myeloerythroid lineages (By similarity). Contributes to the maintenance of steady-state ERBB3 levels by mediating its growth factor-independent degradation. Involved in the degradation of the inhibitor of apoptosis BIRC6 and thus is an important regulator of cell death by promoting apoptosis. Acts also as a PARK2 modifier that accelerates its degradation, resulting in a reduction of PARK2 activity, influencing the balance of intracellular redox state.
    • Tissue specificityDetected in ovary, testis and prostate.
    • PathwayProtein modification; protein ubiquitination.
    • Sequence similaritiesContains 1 RING-type zinc finger.
      Contains 1 SIAH-type zinc finger.
    • Post-translational
      modifications
      Autoubiquitinated. Autoubiquitination leads to proteasomal degradation. Deubiquitinated by USP8 to get stabilized which induces apoptosis.
    • Information by UniProt
    • Database links
    • Alternative names
      • 4930511A05Rik antibody
      • 4933415P08Rik antibody
      • E3 ubiquitin protein ligase NRDP1 antibody
      • E3 ubiquitin-protein ligase NRDP1 antibody
      • Fetal Liver RING finger protein antibody
      • FLRF antibody
      • MGC45228 antibody
      • Neuregulin receptor degradation protein 1 antibody
      • NRDP1 antibody
      • RING finger protein 41 antibody
      • rnf41 antibody
      • RNF41_HUMAN antibody
      • SBBI03 antibody
      see all

    Anti-RNF41 antibody images

    • Immunohistochemistry analysis of formalin-fixed, paraffin-embedded Human prostate adenocarcinoma, using 1/250 ab84409 followed by DAB staining.
    • Immunohistochemistry analysis of formalin-fixed, paraffin-embedded Human metastatic lymph node, using 1/250 ab84409 followed by DAB staining.

    References for Anti-RNF41 antibody (ab84409)

    ab84409 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab84409.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"